The involvement of Galectins in the modulation of the JAK/STAT pathway in myeloproliferative neoplasia

BACKGROUND: In patients with myeloproliferative neoplasia (MPN) the development of fibrosis and increased vessel density correlate with poor prognosis. The JAK2(V617F) mutation constitutively activates JAK2, which phosphorylates signal transducer activator of transcription (STAT), up-regulating vasc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Koopmans, Suzanne M, Bot, Freek J, Schouten, Harry C, Janssen, Jannie, van Marion, Arienne MW
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2012
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3384397/
https://ncbi.nlm.nih.gov/pubmed/22762031
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars